Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells
Cancer Letters · 2023-12 · 578 · 216458
DOI: 10.1016/j.canlet.2023.216458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023-12. Verfasst von Wei-Jyun Hua und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan; Institute of Traditional Medicine, Natio…. Hauptthemen laut MEDLINE: Lung Neoplasms, Ganoderma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, National Science and Technology Council.
Abstract (Originalsprache)
Epidermal growth factor receptor (EGFR) abnormalities relevant to tumor progression. A newly developed strategy for cancer therapy is induction of EGFR degradation. GMI, an immunomodulatory protein from the medicinal mushroom Ganoderma microsporum, exhibits anticancer activity. However, its role in the intracellular trafficking and degradation of EGFR remains unclear. In this study, we discovered that GMI inhibits the phosphorylation of multiple tyrosine kinases. Specifically, GMI was discovered to suppress lung cancer cells harboring both wild-type and mutant EGFR by inhibiting EGFR dimerization and eliminating EGFR-mediated signaling. Functional studies revealed that GMI binds to the extracellular segment of EGFR. GMI interacts with EGFR to induce phosphorylation of EGFR at tyrosine1045, which triggers clathrin-dependent endocytosis and degradation of EGFR. Furthermore, in the mouse models, GMI was discovered to suppress tumor growth. Knockdown of EGFR in lung cancer cells abolishes GMI's anticancer activity in vivo and in vitro. Our results reveal the interaction mechanisms through which GMI induces EGFR degradation and abolishes EGFR-mediated intracellular pathway. Our study indicates that GMI is an EGFR degrader for inhibiting EGFR-expressing tumor growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan; Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Faculty of Medicine, National Yang Ming Chiao Tung University, Taiwan; Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taiwan.
- College of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; LO-Sheng Hospital Ministry of Health and Welfare, Taipei, Taiwan; School of Oral Hygiene, College of Oral Medicine, Taipei Med…
- Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Förderung
- Ministry of Science and Technology, Taiwan
- National Science and Technology Council
Zitieren
APA
Hua, W. J., Yeh, H., Lin, Z. H., Tseng, A. J., Huang, L. C., Qiu, W. L., Tu, T. H., Wang, D. H., Hsu, W. H., Hwang, W. L., & Lin, T. Y. (2023). Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells. Cancer Letters, 578, 216458. https://doi.org/10.1016/j.canlet.2023.216458
Vancouver
Hua WJ, Yeh H, Lin ZH, Tseng AJ, Huang LC, Qiu WL, et al. Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells. Cancer Letters. 2023;578:216458. doi:10.1016/j.canlet.2023.216458
BibTeX
@article{Hua2023,
author = {Hua, Wei-Jyun and Yeh, Hsin and Lin, Zhi-Hu and Tseng, Ai-Jung and Huang, Li-Chen and Qiu, Wei-Lun and Tu, Tsung-Hsi and Wang, Ding-Han and Hsu, Wei-Hung and Hwang, Wei-Lun and Lin, Tung-Yi},
title = {Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells},
journal = {Cancer Letters},
year = {2023},
volume = {578},
pages = {216458},
doi = {10.1016/j.canlet.2023.216458}
}
EUVIMED